Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Prefrontal myo-inositol concentration and visuospatial functioning among diabetic depressed patients.

Haroon E, Watari K, Thomas A, Ajilore O, Mintz J, Elderkin-Thompson V, Darwin C, Kumaran S, Kumar A.

Psychiatry Res. 2009 Jan 30;171(1):10-9. doi: 10.1016/j.pscychresns.2008.03.006. Epub 2008 Dec 18.

PMID:
19097871
2.

Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy.

Ajilore O, Haroon E, Kumaran S, Darwin C, Binesh N, Mintz J, Miller J, Thomas MA, Kumar A.

Neuropsychopharmacology. 2007 Jun;32(6):1224-31. Epub 2006 Dec 20.

3.

Decreased prefrontal Myo-inositol in major depressive disorder.

Coupland NJ, Ogilvie CJ, Hegadoren KM, Seres P, Hanstock CC, Allen PS.

Biol Psychiatry. 2005 Jun 15;57(12):1526-34.

PMID:
15953489
4.

Focal subcortical biophysical abnormalities in patients diagnosed with type 2 diabetes and depression.

Kumar A, Gupta R, Thomas A, Ajilore O, Hellemann G.

Arch Gen Psychiatry. 2009 Mar;66(3):324-30. doi: 10.1001/archgenpsychiatry.2008.548.

PMID:
19255382
5.

Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients.

Caetano SC, Fonseca M, Olvera RL, Nicoletti M, Hatch JP, Stanley JA, Hunter K, Lafer B, Pliszka SR, Soares JC.

Neurosci Lett. 2005 Aug 26;384(3):321-6.

PMID:
15936878
6.

[Gender differences in the neurocognitive components of depression].

Sárosi A, Gonda X, Balogh G, Székely A, Sasvári M, Faludi G.

Neuropsychopharmacol Hung. 2008 Oct;10(4):191-9. Hungarian.

7.

Executive dysfunction and visuospatial ability among depressed elders in a community setting.

Elderkin-Thompson V, Kumar A, Mintz J, Boone K, Bahng E, Lavretsky H.

Arch Clin Neuropsychol. 2004 Aug;19(5):597-611.

8.

Proton magnetic resonance spectroscopy of late-life major depressive disorder.

Chen CS, Chiang IC, Li CW, Lin WC, Lu CY, Hsieh TJ, Liu GC, Lin HF, Kuo YT.

Psychiatry Res. 2009 Jun 30;172(3):210-4. doi: 10.1016/j.pscychresns.2009.01.003. Epub 2009 Mar 20.

PMID:
19303260
9.

Increased myo-inositol level in dorsolateral prefrontal cortex in migraine patients with major depression.

Lirng JF, Chen HC, Fuh JL, Tsai CF, Liang JF, Wang SJ.

Cephalalgia. 2015 Jul;35(8):702-9. doi: 10.1177/0333102414557048. Epub 2014 Oct 23.

PMID:
25341532
10.

Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes.

Herting B, Beuthien-Baumann B, Pöttrich K, Donix M, Triemer A, Lampe JB, von Kummer R, Herholz K, Reichmann H, Holthoff VA.

Mov Disord. 2007 Mar 15;22(4):490-7.

PMID:
17260333
11.

Brain metabolites and cognitive function among older depressed and healthy individuals using 2D MR spectroscopy.

Elderkin-Thompson V, Thomas MA, Binesh N, Mintz J, Haroon E, Dunkin JJ, Kumar A.

Neuropsychopharmacology. 2004 Dec;29(12):2251-7.

12.

[Visuospatial context processing in untreated schizophrenic patients and relation to disorganization syndrome].

Longevialle-Hénin R, Bourdel MC, Willard D, Lôo H, Olié JP, Poirier MF, Krebs MO, Amado I.

Encephale. 2005 May-Jun;31(3):323-9. French.

PMID:
16142047
13.

Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.

Dierckx E, Engelborghs S, De Raedt R, De Deyn PP, Ponjaert-Kristoffersen I.

Psychol Med. 2007 May;37(5):747-55. Epub 2006 Dec 13.

PMID:
17164030
14.

Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus.

Lyoo IK, Yoon SJ, Musen G, Simonson DC, Weinger K, Bolo N, Ryan CM, Kim JE, Renshaw PF, Jacobson AM.

Arch Gen Psychiatry. 2009 Aug;66(8):878-87. doi: 10.1001/archgenpsychiatry.2009.86.

PMID:
19652127
15.

Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla.

Frey R, Metzler D, Fischer P, Heiden A, Scharfetter J, Moser E, Kasper S.

J Psychiatr Res. 1998 Nov-Dec;32(6):411-20.

PMID:
9844958
16.

Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.

Kaymak SU, Demir B, Oğuz KK, Sentürk S, Uluğ B.

Psychiatry Clin Neurosci. 2009 Jun;63(3):350-6. doi: 10.1111/j.1440-1819.2009.01951.x.

17.

Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study.

Wang Y, Jia Y, Xu G, Ling X, Liu S, Huang L.

J Affect Disord. 2012 Feb;136(3):620-6. doi: 10.1016/j.jad.2011.10.020. Epub 2011 Nov 29.

PMID:
22129769
18.

Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.

Hasler G, Neumeister A, van der Veen JW, Tumonis T, Bain EE, Shen J, Drevets WC, Charney DS.

Biol Psychiatry. 2005 Dec 15;58(12):969-73. Epub 2005 Jul 25.

PMID:
16043137
19.

Prefrontal inositol levels and implicit decision-making in healthy individuals and depressed patients.

Jollant F, Richard-Devantoy S, Ding Y, Turecki G, Bechara A, Near J.

Eur Neuropsychopharmacol. 2016 Aug;26(8):1255-63. doi: 10.1016/j.euroneuro.2016.06.005. Epub 2016 Jun 21.

PMID:
27342631
20.

Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy.

Merkl A, Schubert F, Quante A, Luborzewski A, Brakemeier EL, Grimm S, Heuser I, Bajbouj M.

Biol Psychiatry. 2011 Apr 15;69(8):772-9. doi: 10.1016/j.biopsych.2010.08.009. Epub 2010 Oct 16.

PMID:
20951980

Supplemental Content

Support Center